Cycloheptanamine

Cycloheptanamine

SCHEMBL50158

NC1CCCCCC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2735037 1.00 THRB (0.50)
Cyclohexylamine SCHEMBL1330985 1.00
SCHEMBL20830445 1.00 THRB (0.50)
SCHEMBL20726193 1.00 THRB (0.50)
SCHEMBL23379885 1.00 THRB (0.50)
SCHEMBL23379889 1.00 THRB (0.50)
SCHEMBL21416372 1.00 THRB (0.50)
SCHEMBL24893550 1.00 THRB (0.50)
SCHEMBL20858602 1.00 THRB (0.50)
SCHEMBL18476391 1.00 THRB (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5440 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122076494-A Preparation method and application of tin selenide loaded mordenite catalyst 2026-05-26 CN claimed
CN-122036730-A Gαq/11 protein inhibitor with purine skeleton, and preparation method and application thereof 中山大学 2026-05-15 CN claimed
CN-122011028-A Method for efficiently preparing various substituted chiral phosphoramides 上海交通大学 2026-05-12 CN claimed
CN-122010132-A Composite molecular sieve of beta-configuration molecular sieve and MOR-configuration molecular sieve, and manufacturing method and application thereof 中国石油化工股份有限公司 2026-05-12 CN claimed
US-12559377-B2 Method of synthesizing a molecular sieve of MWW framework type EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-02-24 US claimed
US-20260028497-A1 Conductive Dispersions And Methods Of Manufacture NANOTECH ENERGY INC (US) 2026-01-29 US claimed
US-12522511-B2 Methods and systems for treatment of limestone to form vaterite ARELAC, INC. (US) 2026-01-13 US claimed
US-12516212-B2 Conductive dispersions with ultrathin graphene NANOTECH ENERGY, INC. (US) 2026-01-06 US claimed
US-12514827-B1 Coated zeolitic imidazolate framework (ZIF-8) as an efficient carrier for the Cycloheptylamine hydrochloride for the treatment of diabetes UNITED ARAB EMIRATES UNIVERSITY (AE) 2026-01-06 US claimed
US-20250387385-A1 TREATMENT FOR GLOMERULAR DISEASES ZYDUS LIFESCIENCES LIMITED (IN) 2025-12-25 US claimed
EP-0407344-A2 Pharmaceutical preparation for topical application CIBA-GEIGY AG (CH) 1991-01-09 EP claimed
EP-0395046-A2 Process for oxidizing saturated primary amines to oximes ENICHEM S.p.A. (IT) 1990-10-31 EP claimed
EP-0385014-A1 Process for preparation of substituted aminomethylphosphonic acids CROMPTON &amp; KNOWLES CORPORATION (US) 1990-09-05 EP claimed
US-4830788-A Process for preparation of substituted-aminomethylphosphonic acids CROMPTON & KNOWLES CORPORATION (US) 1989-05-16 US claimed
US-4759861-A Consists of an aliphatic mono- or di-carboxylic acid, a dimer or trimer of said dicarboxylic acid, petroleum sulfonic acid and naphthenic acid or salt NIPPON OIL CO., LTD. (JP) 1988-07-26 US claimed
EP-0092647-B1 NEW ACTIVE COMPOUNDS IN THE TREATMENT OF ULCERS AND SKIN ALLERGY SYMPTOMS MAGIS FARMACEUTICI S.p.A. (IT) 1987-01-14 EP claimed
US-4569994-A Dibenzo[b,d]pyranyloxyaminopropanols PENNWALT CORPORATION 1986-02-11 US claimed
EP-0092647-A1 New active compounds in the treatment of ulcers and skin allergy symptoms MAGIS FARMACEUTICI S.p.A. (IT) 1983-11-02 EP claimed
US-4261989-A Geldanamycin derivatives and antitumor drug KAKEN CHEMICAL CO. LTD. (JP) 1981-04-14 US claimed
US-3956339-A 4-Pyridinio-5-pyrazolone salts, process for their preparation and their use FUJI PHOTO FILM CO., LTD. (JA) 1976-05-11 US claimed